You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)與豫園股份訂立股權和債權轉讓合同
格隆匯 04-27 07:15

格隆匯 4 月 27日丨復星醫藥(02196.HK)發佈公吿,2021年4月26日,公司附屬公司禪城醫院作為賣方、復星醫療作為賣方及佛山禪曦作為目標公司作為買方與豫園股份作為買方訂立轉讓合同,據此,禪城醫院及復星醫療同意以約人民幣1.76億元的總對價向豫園股份轉讓出售股權,並以約人民幣3.739億元的總對價向豫園股份轉讓出售債權。

出售事項完成後,豫園股份(或其依約指定的附屬公司)將持有佛山禪曦100%的股權,佛山禪曦將不再為公司的附屬公司。佛山禪曦系一間於中國成立的有限責任公司,截至本公吿日期,由公司附屬公司禪城醫院及復星醫療分別持有其60%及40%的股權,佛山禪曦係為開展“禪醫健康城綜合體項目”而設立的公司。

為滿足禪城醫院發展需要,發揮其在華南地區的醫療優勢和輻射示範作用,2018年8月經公司第七屆第六十九次董事會審議批准,同意推進建設實施“禪醫健康城綜合體項目”。由於該項目所涉土地性質為醫療衞生、社會福利混合用地,並相容二類居住用地和商業商務用地,由於該宗土地使用權系整體招拍掛、無法分割,故由專門設立的項目公司(即佛山禪曦)作為土地使用權的摘牌主體,並整體推進該項目實施。

鑑於佛山禪曦“禪醫健康城綜合體項目”中的商住等部分地產業務與集團主營業務無關,但禪城醫院與佛山禪曦已就該項目用於運營婦女兒童醫學中心、養護院的相關物業已簽訂定製協議,約定於定製工程完成竣工驗收備案後及時交付禪城醫院使用,並以資產轉讓的方式將定製工程的產權辦理至禪城醫院名下。因此,為聚焦主業,集團擬對佛山禪曦股權進行整體轉讓。

訂立轉讓合同為滿足禪城醫院重點擴容和發展婦女兒童醫學中心、養護院提供醫療場地保障,進一步發揮其專業特色和優勢,滿足大灣區不斷增加的高端醫療需求的同時,也有利於集團聚焦主業。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account